In Brazil and Latin America, hospitals typically discharge newborns within 72 hours. This limited observation period often prevents doctors from identifying subtle neurological conditions that require longer-term monitoring.

Research revealed that many developmental delays go undetected due to infrequent checkups and limited access to specialized care, particularly in underserved populations.

Early detection of developmental disorders in infants is crucial, as many neurological diseases can show signs as early as 2 weeks after birth.

However, identifying atypical movement patterns would require experts to monitor babies constantly at their homes - Something impractical for most families. As a result, by the time diagnoses come, it's often years too late - costing infants precious time they can't afford to lose

Baby Minder is a crib-mounted medical device that continuously monitors the movements of infants and toddlers (ages 0–24 months) using advanced computer vision technology.

Once installed, it records the baby’s movements in the crib and uploads them in real-time to a cloud database. The cloud-based AI compares these movements against datasets of typical and atypical motor patterns.

When irregularities are detected, Baby Minder sends an alert to the designated pediatrician. The doctor receives a short video showing the signs of a possible condition and a preliminary analysis. The pediatrician reviews the data to determine whether further investigation or intervention is needed.

By flagging potential indicators of conditions like epilepsy, autism, cerebral palsy, and dozens more, Baby Minder enables timely interventions based on concrete data, fostering peace of mind for doctors and parents and improving outcomes for infants and toddlers.

Baby Minder provides extended observation time to help the 1 in 6 children who are estimated to have a neurological condition, anticipating the diagnosis of certain conditions by up to 6.5 years.

It makes traditional daily hospital monitoring 40 times more cost-effective, which is particularly essential for Brazil’s public healthcare system (SUS).

The daily cost of neonatal ICU observation by SUS ranges from $500 to $600 per day. By enabling specific home monitoring, Baby Minder has the potential to save up to $50 million annually for Brazil's public health system, excluding additional savings from early diagnoses.

In the private sector, neonatal monitoring costs are even higher, making Baby Minder an equally valuable adjunctive tool. While it does not replace hospital monitoring, it alleviates overcrowded hospital corridors, reduces the risk of infections during pandemics, and frees up beds for emergencies.

This platform optimizes healthcare resources while improving outcomes for infants.

Impact & Scalability - Open source the tech for all baby monitors - Hospital monitoring costs decrease 18x - Free access to monitoring for up 2 million babies - Estimated cost $75